A 6927 introduced

Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Type: bill Introduced: March 18, 2025 Last action: May 31, 2026 👁 1 views

📌 Latest Action

PRINT NUMBER 6927A

Raw Data (for developers)
{"id": "ocd-bill/a91785e5-4ce7-4b6d-9a35-d0e340a681d4", "session": "2025-2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:ny/government", "name": "New York", "classification": "state"}, "from_organization": {"id": "ocd-organization/26bb6306-85f0-4d10-bff7-d1cd5bdc0865", "name": "Assembly", "classification": "lower"}, "identifier": "A 6927", "title": "Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy", "classification": ["bill"], "subject": [], "extras": {}, "created_at": "2025-03-18T21:25:12.145307+00:00", "updated_at": "2026-05-31T01:49:53.178561+00:00", "openstates_url": "https://openstates.org/ny/bills/2025-2026/A6927/", "first_action_date": "2025-03-18", "latest_action_date": "2026-05-28", "latest_action_description": "PRINT NUMBER 6927A", "latest_passage_date": ""}